Sartorius Stedim Biotech Reports Strong Half-Year Financial Performance with 9.4% Revenue Growth in 2025
Sartorius Stedim Biotech has reported strong half-year results for 2025, with a 9.4% increase in sales revenue to 1,490 million euros.
2 minutes to read